HCM ACQUISITION CORP : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)

Item 1.01. Entry into a Material Definitive Agreement.

On January 25, 2022, HCM Acquisition Corp (the "Company") consummated its initial public offering (the "IPO") of 28,750,000 units, including 3,750,000 units issued pursuant to the full exercise of the underwriter of its over-allotment option (the "Units"). Each Unit consists of one Class A ordinary share, par value $0.0001 per share ("Class A Ordinary Shares"), and one-half of one redeemable warrant of the Company ("Warrant"), with each whole Warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $287,500,000.

In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company's Registration Statement on Form S-1 (File No. 333-253673) related to the IPO, originally filed with the U.S. Securities and Exchange Commission (the "Commission") on March 1, 2021 (as amended, the "Registration Statement"):

    ?   An Underwriting Agreement, dated January 20, 2022, by and among the
        Company, Cantor Fitzgerald & Co. (the "Underwriter"), a copy of which is
        attached as Exhibit 1.1 hereto and incorporated herein by reference.
    ?   A Warrant Agreement, dated January 20, 2022, by and between the Company
        and Continental Stock Transfer & Trust Company, as warrant agent, a copy
        of which is attached as Exhibit 4.4 hereto and incorporated herein by
        reference.
    ?   An Investment Management Trust Agreement, dated January 20, 2022, by and
        between the Company and Continental Stock Transfer & Trust Company, as
        trustee, a copy of which is attached as Exhibit 10.1 hereto and
        incorporated herein by reference.
    ?   A Registration Rights Agreement, dated January 20, 2022, by and among the
        Company, the Company's sponsor, HCM Investor Holdings, LLC (the
        "Sponsor") and the Underwriter, a copy of which is attached as Exhibit
        10.2 hereto and incorporated herein by reference.
    ?   A Private Placement Warrants Purchase Agreement, dated January 20, 2022
        (the "Sponsor Warrant Purchase Agreement"), by and between the Company
        and the Sponsor, a copy of which is attached as Exhibit 10.3(a) hereto
        and incorporated herein by reference.
    ?   A Private Placement Warrants Purchase Agreement, dated January 20, 2022
        (the "Underwriter Warrant Purchase Agreement," and together with the
        Sponsor Warrant Purchase Agreement, the "Warrant Purchase Agreements"),
        by and between the Company and the Underwriter, a copy of which is
        attached as Exhibit 10.3(b) hereto and incorporated herein by reference.
    ?   A Letter Agreement, dated January 20, 2022, by and among the Company, its
        officers, its directors and the Sponsor, a copy of which is attached as
        Exhibit 10.7 hereto and incorporated herein by reference.
    ?   An Administrative Support Agreement, dated January 20, 2022, by and among
        the Company and the Sponsor, a copy of which is attached as Exhibit 10.8
        hereto and incorporated herein by reference.

Item 3.02. Unregistered Sales of Equity Securities.

Simultaneously with the closing of the IPO, pursuant to the Warrant Purchase Agreements, the Company completed the private sale of an aggregate of 13,000,000 warrants (the "Private Placement Warrants") to the Sponsor and the Underwriter at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $13,000,000. The Private Placement Warrants are identical to the Warrants included in the Units sold as part of the Units in the IPO, except as otherwise disclosed in the Registration Statement. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

--------------------------------------------------------------------------------

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

The Company's Amended and Restated Memorandum and Articles of Association (the "Memorandum and Articles") was approved on January 20, 2022. A description of the Memorandum and Articles is contained in the section of the prospectus, dated January 20, 2022 pursuant to Rule 424(b) under the Securities Act (the "Prospectus"), entitled "Description of Securities" and is incorporated herein by reference. The description is qualified in its entirety by reference to the full text of the Memorandum and Articles, which is attached as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated into this Item 5.03 by reference.

Item 8.01. Other Events.

A total of $293,250,000, comprised of $285,000,000 of the proceeds from the IPO (which amount includes $12,500,000 of the underwriter's deferred discount) and $8,250,000 of the proceeds of the sale of the Private Placement Warrants, was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay its taxes (less up to $100,000 interest to pay dissolution expenses), the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company's initial business combination, (ii) the redemption of any of the Company's public shares properly submitted in connection with a stockholder vote to amend the Company's amended and restated certificate of incorporation (a) to modify the substance or timing of its obligation to redeem 100% of the Company's public shares if it does not complete its initial business combination within 15 months from the closing of the IPO or (b) with respect to any other provision relating to stockholders' rights or pre-initial business combination activity and (iii) the redemption of the Company's public shares if it is unable to complete its initial business combination within 15 months from the closing of the IPO, subject to applicable law.

On January 20, 2022, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.

On January 25, 2022, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are being filed herewith:

Exhibit No.   Description
  1.1         Underwriting Agreement, dated January 20, 2022, by and between the
              Company and Cantor Fitzgerald & Co.
  3.1         Amended and Restated Memorandum and Articles of Association.
  4.4         Warrant Agreement, dated January 20, 2022, by and between the Company
              and Continental Stock Transfer & Trust Company, as warrant agent.
  10.1        Investment Management Trust Agreement, dated January 20, 2022, by and
              between the Company and Continental Stock Transfer & Trust Company, as
              trustee.
  10.2        Registration Rights Agreement, dated January 20, 2022, by and among the
              Company, the Sponsor and the Underwriter.
  10.3(a)     Private Placement Warrants Purchase Agreement, dated January 20, 2022,
              by and between the Company and the Sponsor.
  10.3(b)     Private Placement Warrants Purchase Agreement, dated January 20, 2022,
              by and between the Company and the Underwriter.
  10.7        Letter Agreement, dated January 20, 2022, by and among the Company, its
              officers, its directors and the Sponsor.
  10.8        Administrative Support Agreement, dated January 20, 2022, between the
              Company and the Sponsor.
  99.1        Press Release, dated January 20, 2022.
  99.2        Press Release, dated January 25, 2022.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses